Ascites: all 259 studies
Page 1 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT07855640
- Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisNot yet recruitingNCT07755059Not applicable
- Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource SettingsNot yet recruitingNCT07667608
- Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic EncephalopathyNot yet recruitingNCT07634237Not applicable
- Gut Leakage' in DengueRecruitingNCT07602920
- Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisRecruitingNCT07521332Phase 4
- Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot StudyNot yet recruitingNCT07470515Not applicable
- Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive AscitesRecruitingNCT07435701Phase 1/2
- VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)RecruitingNCT07390344
- DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With CirrhosisRecruitingNCT07322237Phase 4
- Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.Not yet recruitingNCT07116369
- Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in ChinaRecruitingNCT07113808
- A Phase I Study of SIM0388 in Participants With Malignant Ascites.RecruitingNCT07007988Phase 1
- Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic ExperimentEnrolling by invitationNCT06995846
- SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant AscitesNot yet recruitingNCT06991478Phase 1/2
- Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic AscitesNot yet recruitingNCT06919523Phase 2
- Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical OutcomeRecruitingNCT06814626Phase 3
- Albumin Assisted Diuresis in Patients with Cirrhosis and AscitesRecruitingNCT06812390Phase 2
- Statin and Beta Blocker Use in Patients With Decompensated CirrhosisRecruitingNCT06764966Phase 2
- Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant AscitesRecruitingNCT06759064Phase 1/2
- Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast CancerRecruitingNCT06658080
- Early TIPS in Patients With Liver Cirrhosis and AscitesRecruitingNCT06576934Not applicable
- High Definition Profiling of Ovarian Cancer AscitesNot yet recruitingNCT06553742
- A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant TumorsNot yet recruitingNCT06496919
- The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant AscitesRecruitingNCT06433869Phase 2
- A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant AscitesNot yet recruitingNCT06415500Phase 1
- Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity TestingRecruitingNCT06413212
- Clinical Value of the Developed Scoring Systems for Predicting Spontaneous Bacterial Peritonitis in Cirrhotic AscitesRecruitingNCT06402071
- Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.Not yet recruitingNCT06245590Not applicable
- Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver FailureRecruitingNCT06224023
- A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal CancerRecruitingNCT06200376Phase 1
- Transitional Care Program for Fluid Overload in CirrhosisRecruitingNCT06174272Not applicable
- Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic PatientsEnrolling by invitationNCT06121479Phase 3
- Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT06046963Phase 2
- Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic CancerRecruitingNCT06016179Phase 1
- High Dose Albumin in Refractory AscitesRecruitingNCT05867602Phase 2
- Intraperitoneal Immune Checkpoint Inhibitor for Malignant AscitesEnrolling by invitationNCT05745233Not applicable
- Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve OutcomesRecruitingNCT05734729Not applicable
- QOL and Sarcopenia in Patients With AscitesRecruitingNCT05726747
- Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory AscitesRecruitingNCT05700708
- The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility TrialNot yet recruitingNCT05569798Not applicable
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsRecruitingNCT05490888Phase 1
- HRS-AKI Treatment With TIPS in Patients With CirrhosisRecruitingNCT05346393Not applicable
- Utility of 2- Octyl Cyanoacrylate (2-OCA)Enrolling by invitationNCT05278013Not applicable
- Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and AscitesRecruitingNCT05056220Phase 3
- 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.RecruitingNCT05025878
- A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic AscitesRecruitingNCT04835480Phase 2
- TIPS in Patients With Decompensated Liver CirrhosisRecruitingNCT04801290
- Cirrhosis Registry of Hospitalized PatientsRecruitingNCT04767945
- Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With CancerRecruitingNCT03943316
- Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic PatientsRecruitingNCT03506893Not applicable
- VICIS - Vienna Cirrhosis StudyRecruitingNCT03267615
- Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®TerminatedNCT05900050Phase 2Results posted
- Achieving Portal Access With Scorpion Post-Approval Study (APASS)TerminatedNCT05765253Not applicableResults posted
- The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.CompletedNCT04675775Not applicableResults posted
- A Study of OsrHSA in Adult Healthy Male and Female VolunteersCompletedNCT04384523Phase 1Results posted
- Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and AscitesCompletedNCT03451292Phase 3Results posted
- BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalCompletedNCT03367247Not applicableResults posted
- Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory AscitesCompletedNCT03107091Phase 2Results posted
- Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCTCompletedNCT02638051Phase 2Results posted
- Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian CancerTerminatedNCT02540356Phase 1/2Results posted
- AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant AscitesTerminatedNCT02417753Phase 2Results posted
- Improving Performance of Paracentesis in Medical Residency TrainingCompletedNCT01403987Not applicableResults posted
- Tolvaptan for Ascites in Cirrhotic PatientsCompletedNCT01292304Phase 4Results posted
- Early TIPS for Ascites StudyTerminatedNCT01236339Not applicableResults posted
- An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant AscitesTerminatedNCT01077063Not applicableResults posted
- Trial of Sunitinib for Refractory Malignant AscitesTerminatedNCT00796861Phase 2Results posted
- AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00396591Phase 2Results posted
- Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00327444Phase 2/3Results posted
- Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesCompletedNCT00326885Phase 2Results posted
- Octreotide in Treating Patients With Cancer-Related Malignant AscitesCompletedNCT00182754Phase 3Results posted
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in CirrhosisCompletedNCT00108355Phase 4Results posted
- Treatment With Octreotide in Patients With LymphangioleiomyomatosisCompletedNCT00005906Phase 2Results posted
- Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant AscitesActive, not recruitingNCT07855757Not applicable
- Lung Point of Care Ultrasound to Guide Albumin Administration in CirrhosisCompletedNCT07072572Phase 3
- Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With AscitesCompletedNCT07023042Not applicable
- A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With AscitesCompletedNCT06911554Phase 3
- Achieving Portal Access With Scorpion Post-Approval Study 2CompletedNCT06856655
- Comparative Study of Secondary Prophylaxis for SBPCompletedNCT06827756Phase 4
- Free Fluid Detection With Telementored eFASTCompletedNCT06594562Not applicable
- PMCF Study of the CE-marked Drainova® ArgentiC CatheterCompletedNCT06436807
- Phase II/III of Recombinant Human Albumin InjectionCompletedNCT06411743Phase 2
- Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent AscitesCompletedNCT06196723
- SGLT-2 Inhibitors in the Treatment of AscitesActive, not recruitingNCT05999773
- S100A8/A9 and Innate Immunity in Liver DiseaseStatus unknownNCT05793983
- The BD Liverty™ TIPS Stent Graft StudyActive, not recruitingNCT05711316Not applicable
- Replicor Compassionate Access ProgramNo longer availableNCT05683548
- Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic PatientsCompletedNCT05621005Phase 2
- Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for ParacentesisStatus unknownNCT05578573Not applicable
- Allopurinol Versus Atorvastatin to Prevent Complications of Liver CirrhosisCompletedNCT05511766Phase 2/3
- PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant AscitesStatus unknownNCT05501340Phase 1/2
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney InjuryStatus unknownNCT05434286
- Application of NGS in Ascites InfectionStatus unknownNCT05352152
- A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney InjuryCompletedNCT05309200Phase 2
- Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant AscitesStatus unknownNCT05303844Phase 1
- Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet StudyStatus unknownNCT05220891
- Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.WithdrawnNCT05084534Not applicable
- Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal VaricesCompletedNCT05057572Not applicable
- Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCTStatus unknownNCT05014594Phase 2